청소년 및 청년 뇌종양 생존자에서 암 관련인지 장애 및 장 미생물 군집을 개선하기위한 가상 가정 기반 운동 중재 (RIS)
청소년 및 청년 뇌종양 생존자에서인지 장애 및 장 미생물 군에 대한 사실상 전달 된 가정 기반 운동 개입 : 파일럿 무작위 대조 시험
This clinical trial evaluates the impact of a research intervention of virtually supervised exercise program (RISE) on cancer-related cognitive impairment (CRCI), physical activity in adolescent and young adult (AYA) brain tumor survivors. This clinical trial also evaluates the impact of RISE on the collection of microorganisms that exist in the intestines (gut microbiome). Up to 45% of AYA brain tumor survivors experience CRCI, including issues with attention and memory. CRCI can have a negative impact on education, independent living and can worsen long-term quality of life. Moderate-intensity levels of exercise, particularly aerobic and resistance training, have been shown to improve cognitive function. Additionally, exercise can change the composition and function of the gut microbiome, which may lead to improved cognitive function. Unfortunately, only about 50% of AYAs with cancer receive exercise information or meet the physical activity recommendations. Tailoring a virtually delivered exercise intervention to meet the unique needs of AYAs may improve access to exercise. Participating in the virtual home-based exercise intervention, RISE, may improve physical activity and cognitive impairment in AYA brain tumor survivors and may also help researchers understand the relationship of exercise on the gut microbiome and cognitive function.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
PRIMARY OBJECTIVES:
I. Evaluate the feasibility of conducting a two-site pilot randomized controlled trial (RCT) to test the RISE in AYA brain tumor survivors.
II. Examine the impact of RISE on CRCI (primary) and physical activity (secondary).
EXPLORATORY OBJECTIVE:
I. Explore the impact of RISE on the gut microbiome diversity and composition.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I (RISE INTERVENTION): Patients receive access to Physitrack and participate in personalized, progressive aerobic training over 30-40 minutes 3-5 days a week and strength training exercises 2 days a week for 12 weeks. Patients also receive active lifestyle behavior coaching over 10 minutes on 2 days a week for weeks 1-4 and then once weekly for weeks 5-12.
ARM II (ATTENTION CONTROL): Patients receive calls from the trainer once weekly for 12 weeks. Patients also wear a Fitbit for 7 days at baseline to week 12.
After completion of study intervention, patients are followed up at week 18.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Jinbing Bai, PhD, RN
- 전화번호: 404-727-2466
- 이메일: jinbing.bai@emory.edu
연구 장소
-
-
Georgia
-
Atlanta, Georgia, 미국, 30322
- 모병
- Emory University Hospital
-
연락하다:
- Emily Bush, BS
- 이메일: emily.bush@emoryhealthcare.org
-
수석 연구원:
- Jinbing Bai, PhD, RN
-
-
Texas
-
Houston, Texas, 미국, 77030
- 모병
- MD Anderson Cancer Center
-
연락하다:
- Keri Schadler, PhD
- 전화번호: 713-794-1035
- 이메일: klschadl@mdanderson.org
-
연락하다:
- Maria Chang Swartz
- 이메일: mchang1@mdanderson.org
-
수석 연구원:
- Keri Schadler, PhD
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Age 15-39 years
- With primary brain tumor with cranial radiotherapy
- 6 months to 4 years post cranial radiotherapy
- Functional Assessment of Cancer Therapy (FACT)-Cognitive Function score < 60 based on self-report (used among AYAs with non-neural cancer)
- Able to provide informed consent/assent
- Able to walk and receive clearance from a provider to participate based on the Physical Activity Readiness Questionnaire
- Currently engaging in < 150 minutes of physical activity per week
- Willing to use smartphone-based applications (app)
Exclusion Criteria:
- Secondary malignancies, germline genetic syndrome, or recurrent disease requiring re-irradiation of the brain
- Moderate to severe traumatic brain injury with brain damage beyond that expected from brain tumor and treatment
- Developmental disorders (e.g., autism) or major psychotic illness (e.g., schizophrenia, depression) to avoid confounding impact related to these disorders
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Arm I (RISE)
Patients receive access to Physitrack and participate in personalized, progressive aerobic training over 30-40 minutes 3-5 days a week and strength training exercises 2 days a week for 12 weeks. Patients also receive active lifestyle behavior coaching over 10 minutes on 2 days a week for weeks 1-4 and then once weekly for weeks 5-12. |
Ancillary studies Participate in personalized, progressive aerobic training
다른 이름들:
Receive active lifestyle behavior coaching
다른 이름들:
Receive access to Physitrack Participating in strength training exercises
다른 이름들:
|
|
활성 비교기: Arm II (attention control)
Patients receive calls from the trainer once weekly for 12 weeks. Patients also wear a Fitbit for 7 days at baseline to week 12. |
Ancillary studies Receive calls from the trainer
다른 이름들:
Wear a Fitbit monitor |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Enrollment
기간: Up to 1.5 years
|
Feasibility will be ≥ 50% enrollment of eligible survivors. Descriptive statistics (e.g., frequency and percentage) will be used. |
Up to 1.5 years
|
|
Adherence to research intervention of virtually supervised exercise program (RISE)
기간: Up to 12 weeks
|
Feasibility will be ≥ 75% adherence to RISE. Descriptive statistics (e.g., frequency and percentage) will be used. |
Up to 12 weeks
|
|
Retention
기간: Up to 12 weeks
|
Feasibility will be ≥ 80% retention at end of intervention. Descriptive statistics (e.g., frequency and percentage) will be used. |
Up to 12 weeks
|
|
Acceptability
기간: Up to 18 weeks
|
Will use an 11-item acceptability questionnaire. A ≥ 4 ("agree" to "strongly agree") per item equates to acceptability. Descriptive statistics (e.g., frequency and percentage) will be used. |
Up to 18 weeks
|
|
Change in physical activity levels
기간: Baseline up to 18 weeks
|
Will be measured by Fitbit. Physical activity estimates considered as valid if the monitor is worn ≥ 10 hours/day on ≥ 4 days. Will use mixed-effect analysis of variance to model the correlation with timepoint and treatment group plus interaction if applicable, clustering on patient to control for repeated measures, and controlling for baseline measure and other covariates, which are considered prognostic or differ at baseline. A 95% level of statistical confidence will be assumed in all statistical testing. |
Baseline up to 18 weeks
|
|
Change in cancer-related cognitive impairment
기간: Baseline up to 18 weeks
|
Will use mixed-effect analysis of variance to model the correlation with timepoint and treatment group plus interaction if applicable, clustering on patient to control for repeated measures, and controlling for baseline measure and other covariates, which are considered prognostic or differ at baseline. A 95% level of statistical confidence will be assumed in all statistical testing. |
Baseline up to 18 weeks
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Gut microbiome
기간: Up to 18 weeks
|
Fecal specimens will be collected for the gut microbiome. Will use mixed-effect analysis of variance to model the correlation with timepoint and treatment group plus interaction if applicable, clustering on patient to control for repeated measures, and controlling for baseline measure and other covariates, which are considered prognostic or differ at baseline. A 95% level of statistical confidence will be assumed in all statistical testing. |
Up to 18 weeks
|
|
Physical function
기간: At baseline and at 12 and 18 weeks
|
Will use mixed-effect analysis of variance to model the correlation with timepoint and treatment group plus interaction if applicable, clustering on patient to control for repeated measures, and controlling for baseline measure and other covariates, which are considered prognostic or differ at baseline. A 95% level of statistical confidence will be assumed in all statistical testing. |
At baseline and at 12 and 18 weeks
|
|
Patient Quality of Life
기간: At baseline and at 12 and 18 weeks
|
Will be assessed by Patient Reported Outcomes Measurement Information System-29 recommended. Will use mixed-effect analysis of variance to model the correlation with timepoint and treatment group plus interaction if applicable, clustering on patient to control for repeated measures, and controlling for baseline measure and other covariates, which are considered prognostic or differ at baseline. A 95% level of statistical confidence will be assumed in all statistical testing. |
At baseline and at 12 and 18 weeks
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: Jinbing Bai, PhD, RN, Emory University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
- 뇌 질환
- 중추신경계 질환
- 신경계 질환
- 부위별 신생물
- 신생물
- 신경계 신생물
- 중추신경계 신생물
- 뇌 신생물
- 건강 관리 품질, 접근 및 평가
- 운동 활동
- 움직임
- 근골격계 생리 학적 현상
- 근골격계 및 신경 생리적 현상
- 조사 기술
- 역학적 방법
- 치료학
- 건강 관리 평가 메커니즘
- 건강 관리의 질
- 공중 위생
- 환경 및 공중 보건
- 물리 치료 양식
- 환자 치료
- 심리 치료
- 행동 학문 및 활동
- 운동 요법
- 복권
- 보도
- 환자 치료의 연속성
- 신체 컨디셔닝, 인간
- 면역 학적 기술
- 유전자 기술
- 역학 연구
- 역학 연구 특성
- 염색질 면역 침전
- 고 처리량 뉴클레오티드 시퀀싱
- 시퀀스 분석
- 서열 분석, DNA
- 면역 침전
- 코호트 연구
- 운동
- 저항 훈련
- 행동 요법
- 염색질 면역 침전 시퀀싱
- 후속 연구
기타 연구 ID 번호
기타 연구 ID 번호
- STUDY00008229
- P30CA138292 (미국 NIH 보조금/계약)
- STUDY00008229 (기타 식별자: Emory University Hospital/Winship Cancer Institute)
- NCI-2025-00181 (레지스트리 식별자: CTRP (Clinical Trial Reporting Program))
- WINSHIP6364-24 (기타 식별자: Emory University Hospital/Winship Cancer Institute)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .